Cargando…

Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?

Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibler, Robert C, Knestrick, Kaelynn E, Reidy, Brooke L, Lax, Daniel N, Powers, Scott W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470380/ https://www.ncbi.nlm.nih.gov/pubmed/36110896 http://dx.doi.org/10.2147/PHMT.S334744

Ejemplares similares

Psychological Interventions for Pediatric Headache Disorders: A 2021 Update on Research Progress and Needs
por: Knestrick, Kaelynn E., et al.
Publicado: (2022)

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

Negative pressure wound therapy: Where are we in 2022?
por: Quacinella, Michael A., et al.
Publicado: (2023)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
por: Hayes, Gemma E., et al.
Publicado: (2016)

Personalized Medicine in Coronary Artery Disease: Where Are We in 2022?
por: Shchekochikhin, Dmitry, et al.
Publicado: (2022)

Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?
por: Pellesi, Lanfranco
Publicado: (2023)

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go
por: Puiggros, Anna, et al.
Publicado: (2014)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
por: Lanni, Alessio, et al.
Publicado: (2023)

Research on Clinical Preventive Services for Adolescents and Young Adults: Where Are We and Where Do We Need to Go?
por: Harris, Sion K., et al.
Publicado: (2016)

OSAS in children: Where are we?
por: de Almeida, Leila Azevedo, et al.
Publicado: (2015)

From Where We've Come to Where We Need to Go: Physiotherapy Management of Chronic Whiplash-Associated Disorder
por: Dickson, Cameron, et al.
Publicado: (2022)

Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
por: Canivet, Clémence M., et al.
Publicado: (2022)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Hepatitis C Vaccination: Where We Are and Where We Need to Be
por: Manne, Vignan, et al.
Publicado: (2021)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?
por: Duraisamy, Ganesh Selvaraj, et al.
Publicado: (2020)

Management of migraine in adolescents
por: Kabbouche, Marielle A, et al.
Publicado: (2008)

Self-management in heart failure: where have we been and where should we go?
por: Gardetto, Nancy Jean
Publicado: (2011)

Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
por: Mazzitelli, Carlotta, et al.
Publicado: (2023)

Craniofacial genetics: Where have we been and where are we going?
por: Weinberg, Seth M., et al.
Publicado: (2018)

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
por: Turnbull, Samantha, et al.
Publicado: (2015)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial
por: Powers, Scott W., et al.
Publicado: (2021)

Where Are We and Where to Next?—The Future of Perianal Crohn’s Disease Management
por: Anandabaskaran, Sulak, et al.
Publicado: (2023)

ScienceMesh 2022: What's next and where do we take it from here
por: Moscicki, Jakub
Publicado: (2022)

Health Psychology: Where Are We And Where Do We Go From Here?
por: Kaplan, Robert M.
Publicado: (2009)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

COVID-19: Where We Are, Where We Need to Be
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jkpi3d68nhc10qdst9gpih9r0p